Hélène Barraud

发表

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Rachida Lebtahi, Mohamed Bouattour, Christophe Aubé, 2017, The Lancet. Oncology.